#METABOLOMICS WORKBENCH shovall_20200517_020906 DATATRACK_ID:2012 STUDY_ID:ST001380 ANALYSIS_ID:AN002300 PROJECT_ID:PR000944
VERSION             	1
CREATED_ON             	May 18, 2020, 8:30 am
#PROJECT
PR:PROJECT_TITLE                 	Fast and sensitive flow-injection mass spectrometry metabolomics by analyzing
PR:PROJECT_TITLE                 	sample specific ion distributions
PR:PROJECT_SUMMARY               	Mass spectrometry based metabolomics is a widely used approach in biotechnology
PR:PROJECT_SUMMARY               	and biomedical research. However, current methods coupling mass spectrometry
PR:PROJECT_SUMMARY               	with chromatography are time-consuming and not suitable for high-throughput
PR:PROJECT_SUMMARY               	analysis of thousands of samples. An alternative approach is flow-injection mass
PR:PROJECT_SUMMARY               	spectrometry (FI-MS) in which samples are directly injected to the ionization
PR:PROJECT_SUMMARY               	source. Here, we show that the sensitivity of Orbitrap FI-MS metabolomics
PR:PROJECT_SUMMARY               	methods is limited by ion competition effect in the detection system. We
PR:PROJECT_SUMMARY               	describe an approach for overcoming this effect by analyzing the distribution of
PR:PROJECT_SUMMARY               	ion m/z values and computationally determining a series of optimal scan ranges.
PR:PROJECT_SUMMARY               	This enables reproducible detection of ~9,000 and ~10,000 m/z features in
PR:PROJECT_SUMMARY               	metabolomics and lipidomics analysis of serum samples, respectively, with a
PR:PROJECT_SUMMARY               	sample scan time of ~15 seconds and duty time of ~30 seconds; a ~50% increase
PR:PROJECT_SUMMARY               	versus current spectral-stitching FI-MS. This approach facilitates
PR:PROJECT_SUMMARY               	high-throughput metabolomics for a variety of applications, including biomarker
PR:PROJECT_SUMMARY               	discovery and functional genomics screens.
PR:INSTITUTE                     	Technion – Israel Institute of Technology
PR:LABORATORY                    	Prof. Tomer Shlomi Lab
PR:LAST_NAME                     	Lagziel
PR:FIRST_NAME                    	Shoval
PR:ADDRESS                       	Technion
PR:EMAIL                         	shovallagziel@gmail.com
PR:PHONE                         	+972-77-8871497
#STUDY
ST:STUDY_TITLE                   	Fast and sensitive flow-injection mass spectrometry metabolomics by analyzing
ST:STUDY_TITLE                   	sample specific ion distributions
ST:STUDY_SUMMARY                 	Mass spectrometry based metabolomics is a widely used approach in biotechnology
ST:STUDY_SUMMARY                 	and biomedical research. However, current methods coupling mass spectrometry
ST:STUDY_SUMMARY                 	with chromatography are time-consuming and not suitable for high-throughput
ST:STUDY_SUMMARY                 	analysis of thousands of samples. An alternative approach is flow-injection mass
ST:STUDY_SUMMARY                 	spectrometry (FI-MS) in which samples are directly injected to the ionization
ST:STUDY_SUMMARY                 	source. Here, we show that the sensitivity of Orbitrap FI-MS metabolomics
ST:STUDY_SUMMARY                 	methods is limited by ion competition effect in the detection system. We
ST:STUDY_SUMMARY                 	describe an approach for overcoming this effect by analyzing the distribution of
ST:STUDY_SUMMARY                 	ion m/z values and computationally determining a series of optimal scan ranges.
ST:STUDY_SUMMARY                 	This enables reproducible detection of ~9,000 and ~10,000 m/z features in
ST:STUDY_SUMMARY                 	metabolomics and lipidomics analysis of serum samples, respectively, with a
ST:STUDY_SUMMARY                 	sample scan time of ~15 seconds and duty time of ~30 seconds; a ~50% increase
ST:STUDY_SUMMARY                 	versus current spectral-stitching FI-MS. This approach facilitates
ST:STUDY_SUMMARY                 	high-throughput metabolomics for a variety of applications, including biomarker
ST:STUDY_SUMMARY                 	discovery and functional genomics screens.
ST:INSTITUTE                     	Technion – Israel Institute of Technology
ST:LAST_NAME                     	Lagziel
ST:FIRST_NAME                    	Shoval
ST:ADDRESS                       	Technion
ST:EMAIL                         	shovallagziel@gmail.com
ST:PHONE                         	+972-77-8871497
#SUBJECT
SU:SUBJECT_TYPE                  	Other
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Sample_1	Treatment:Serum	RAW_FILE_NAME=Sample_1.raw
SUBJECT_SAMPLE_FACTORS           	-	Sample_2	Treatment:Serum	RAW_FILE_NAME=Sample_2.raw
SUBJECT_SAMPLE_FACTORS           	-	Sample_3	Treatment:Serum	RAW_FILE_NAME=Sample_3.raw
SUBJECT_SAMPLE_FACTORS           	-	Sample_4	Treatment:Serum	RAW_FILE_NAME=Sample_4.raw
SUBJECT_SAMPLE_FACTORS           	-	Sample_5	Treatment:Serum	RAW_FILE_NAME=Sample_5.raw
SUBJECT_SAMPLE_FACTORS           	-	Sample_6	Treatment:Serum	RAW_FILE_NAME=Sample_6.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_1	Treatment:Blank	RAW_FILE_NAME=Blank_1.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_2	Treatment:Blank	RAW_FILE_NAME=Blank_2.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_3	Treatment:Blank	RAW_FILE_NAME=Blank_3.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_4	Treatment:Blank	RAW_FILE_NAME=Blank_4.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_5	Treatment:Blank	RAW_FILE_NAME=Blank_5.raw
SUBJECT_SAMPLE_FACTORS           	-	Blank_6	Treatment:Blank	RAW_FILE_NAME=Blank_6.raw
#COLLECTION
CO:COLLECTION_SUMMARY            	FI-MS method optimization was performed with commercially available serum, Human
CO:COLLECTION_SUMMARY            	AB Serum (Biological Industries USA, Inc., USA). Matrix effect experiments and
CO:COLLECTION_SUMMARY            	biological applications were performed with 98 serum samples of healthy
CO:COLLECTION_SUMMARY            	individuals obtained from Rambam Hospital, Haifa, Israel (IRB 0481-18-RMB).
CO:SAMPLE_TYPE                   	Blood (serum)
#TREATMENT
TR:TREATMENT_SUMMARY             	To extract metabolites and lipids from serum samples, we mixed 20 µL of serum
TR:TREATMENT_SUMMARY             	with an extraction solution for metabolomics analysis and 10 µL for lipidomics
TR:TREATMENT_SUMMARY             	in 96-deep well plates. For lipidomics analysis, we utilized 100 µL of
TR:TREATMENT_SUMMARY             	2-propanol/methanol (6:1, v/v); and for metabolomics analysis, 100 µL of
TR:TREATMENT_SUMMARY             	methanol/acetonitrile/water (5:3:1, v/v/v). After 10 min of vortexing, 800 rpm,
TR:TREATMENT_SUMMARY             	precipitated proteins were separated by centrifugation for 20 min at 4 °C and
TR:TREATMENT_SUMMARY             	4000 rcf; supernatants were stored at -80 °C prior the analysis.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	To extract metabolites and lipids from serum samples, we mixed 20 µL of serum
SP:SAMPLEPREP_SUMMARY            	with an extraction solution for metabolomics analysis and 10 µL for lipidomics
SP:SAMPLEPREP_SUMMARY            	in 96-deep well plates. For lipidomics analysis, we utilized 100 µL of
SP:SAMPLEPREP_SUMMARY            	2-propanol/methanol (6:1, v/v); and for metabolomics analysis, 100 µL of
SP:SAMPLEPREP_SUMMARY            	methanol/acetonitrile/water (5:3:1, v/v/v). After 10 min of vortexing, 800 rpm,
SP:SAMPLEPREP_SUMMARY            	precipitated proteins were separated by centrifugation for 20 min at 4 °C and
SP:SAMPLEPREP_SUMMARY            	4000 rcf; supernatants were stored at -80 °C prior the analysis.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	None (Direct infusion)
CH:INSTRUMENT_NAME               	none
CH:COLUMN_NAME                   	none
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	UNSPECIFIED
MS:MS_COMMENTS                   	To determine the number of reproducibly detected m/z features by a specific
MS:MS_COMMENTS                   	FI-MS method configuration, we performed 6 repeated injections of the biological
MS:MS_COMMENTS                   	sample from the same vial followed by the injection of 6 blank samples (i.e.
MS:MS_COMMENTS                   	sample preparation protocol applied to a water sample) and identified
MS:MS_COMMENTS                   	reproducibly detected features based on low RSD (<30%) and high SNR (>4)
MS:MS_RESULTS_FILE               	ST001380_AN002300_Results.txt	UNITS:intensity	Has m/z:Yes	Has RT:No	RT units:No RT data
#END